Pharma Journalist 9001 posts 0 comments

Ionis Pharmaceuticals has received U.S. Food and Drug Administration (FDA) approval for TRYNGOLZA (olezarsen), a first-of-its-kind therapy designed to reduce triglyceride levels and…
Read More...

RQ Bio has secured $115 million (£85.5 million) in an oversubscribed Series A financing, providing the biotechnology company with significant resources to advance the clinical…
Read More...

Merck has secured European Union approval for a new perioperative treatment regimen combining KEYTRUDA (pembrolizumab) and Padcev (enfortumab vedotin-ejfv) for adults with resectable…
Read More...

Merck KGaA, Darmstadt, Germany, has announced a definitive agreement to acquire U.S.-based life sciences company Bio-Techne Corporation in an all-cash transaction valued at…
Read More...

Ionis Partners with Recordati to Commercialize Alexander Disease Therapy Outside U.S. Ionis Pharmaceuticals has entered into a strategic licensing agreement with Recordati to expand…
Read More...

Remix Therapeutics and Passage Bio have agreed to merge in an all-stock transaction, creating a combined biotechnology company focused on advancing RNA-targeted therapies for cancer and…
Read More...

ŌURA and LillyDirect have announced a new collaboration aimed at helping people using GLP-1 weight management medicines better manage their health through wearable technology and…
Read More...

Eli Lilly and Company has completed its acquisition of Centessa Pharmaceuticals plc, strengthening its neuroscience pipeline with promising therapies aimed at treating narcolepsy and…
Read More...

Bayer has entered into a strategic drug discovery collaboration with Iambic Therapeutics to accelerate the development of new small-molecule medicines using artificial intelligence. The…
Read More...

Lonza has entered into a new licensing agreement with biotechnology company InduPro to support the development of next-generation antibody-drug conjugate (ADC) therapies for cancer. The…
Read More...